In conclusion, we found that DLGAP4 is upregulated in HCC and that high DLGAP4 expression is associated with the clinical progression of HCC and is an independent risk factor for OS in HCC patients. The gene discussed is DLGAP4; the disease is hepatocellular carcinoma.